AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Louvet, C Andre, T Hammel, P Selle, F Landi, B Cattan, S Fonck, M Flesch, M Colin, P Balosso, J Ruszniewski, P de Gramont, A
Citation: C. Louvet et al., Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine foradvanced pancreatic adenocarcinoma (FOLFUGEM), ANN ONCOL, 12(5), 2001, pp. 675-679

Authors: Andre, T Balosso, J Louvet, C Hannoun, L Houry, S Huguier, M Colonna, M Lotz, JP De Gramont, A Bellaiche, A Parc, R Touboul, E Izrael, V
Citation: T. Andre et al., Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: Results of a feasibility study, INT J RAD O, 46(4), 2000, pp. 903-911

Authors: Bolla, M Artignan, X Balosso, J Chirpaz, E
Citation: M. Bolla et al., Is postoperative irradiation after radical prostatectomy necessary? Arbiter, EUR J CANC, 35(13), 1999, pp. 1768-1770

Authors: Andre, T Balosso, J
Citation: T. Andre et J. Balosso, Chemotherapy, combined radiochemotherapy and new therapeutic approaches for adenocarcinoma of the pancreas, J CHIR, 136(6), 1999, pp. 309-317

Authors: Bolla, M Artignan, X Chirpaz, E Balosso, J Descotes, JL
Citation: M. Bolla et al., Current data on combined radiotherapy plus hormone therapy in localized and locally advanced cancer of the prostate, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 260-265

Authors: Andre, T Chastre, E Kotelevets, L Vaillant, JC Louvet, C Balosso, J Le Gall, E Prevot, S Gespach, C
Citation: T. Andre et al., Tumoral angiogenesis: physiopathology, prognostic value and therapeutical prospects, REV MED IN, 19(12), 1998, pp. 904-913

Authors: Balosso, J Hennequin, C Giocanti, N Favaudon, V
Citation: J. Balosso et al., Radio-chemotherapy: biological basis, TREATMENT OPTIMIZATION FOR LUNG CANCER, 1998, pp. 197-205
Risultati: 1-7 |